Appropriateness of Empirical Treatment and Outcome in Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing Bacteria

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis

(2012) Wouter C. Rottier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type ST131 and Non-ST131 Clones: Comparison of Demographic Data, Clinical Features, and Mortality

(2011) Hsing-Chun Chung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical and Molecular Characteristics of Extended-Spectrum- β-Lactamase-Producing Escherichia coli Causing Bacteremia in the Rotterdam Area, Netherlands

(2011) Akke K. van der Bij et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

 -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum  -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

(2011) J. Rodriguez-Bano et al.   CLINICAL INFECTIOUS DISEASES

Can We Really Use ss-Lactam/ss-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ss-Lactamase-Producing Bacteria?

(2011) F. Perez et al.   CLINICAL INFECTIOUS DISEASES

Multi-centre evaluation of a phenotypic extended spectrum β -lactamase detection guideline in the routine setting

(2011) T.N. Platteel et al.   CLINICAL MICROBIOLOGY AND INFECTION

EUCAST expert rules in antimicrobial susceptibility testing

(2011) R. Leclercq et al.   CLINICAL MICROBIOLOGY AND INFECTION

The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria

(2011) F. G. De Rosa et al.   INFECTION

European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009)

(2011) et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae

(2011) Shu-Shen Wang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum  -Lactamases: a Prospective Study with Swedish Volunteers

(2010) T. Tangden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

(2010) M. Paul et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by Enterobacteriaceae Producing Extended-Spectrum  -Lactamases

(2010) D. Marchaim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

(2010) Johann D.D. Pitout   DRUGS

Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum- -Lactamase-Producing Escherichia coli

(2010) J. Rodriguez-Bano et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients

(2009) Ronen Ben‐Ami et al.   CLINICAL INFECTIOUS DISEASES

Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome

(2009) M. Ortega et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bloodstream Infections Caused by Extended-Spectrum- -Lactamase- Producing Escherichia coli: Risk Factors for Inadequate Initial Antimicrobial Therapy

(2008) M. Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE

Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: Importance of international travel

(2008) Kevin B. Laupland et al.   JOURNAL OF INFECTION